Prostate Cell News Volume 13.27 | Nov 18 2022

    0
    21








    2022-11-18 | PCN 13.27


    Prostate Cell News by STEMCELL Technologies
    Vol. 13.27 – 18 November, 2022
    TOP STORY

    Stromal FOXF2 Suppresses Prostate Cancer Progression and Metastasis by Enhancing Antitumor Immunity

    Researchers showed that increasing prostatic stromal Foxf2 suppressed the growth and progression of both syngeneic and autochthonous mouse prostate cancer models in an immunocompetent context.
    [Nature Communications]

    Full Article
    Return to your lab safely and efficiently with these guides and resources so that you can focus more on moving your research goals forward.
    PUBLICATIONSRanked by the impact factor of the journal

    The Transcriptional Terminator XRN2 and the RNA-Binding Protein Sam68 Link Alternative Polyadenylation to Cell Cycle Progression in Prostate Cancer

    Investigators uncovered a mechanism of alternative polyadenylation regulation impinging on the interaction between the exonuclease XRN2 and the RNA-binding protein Sam68, whose increased expression in prostate cancer was promoted by the transcription factor MYC.
    [Nature Structural & Molecular Biology]

    Abstract

    UGT2B28 Accelerates Prostate Cancer Progression through Stabilization of the Endocytic Adaptor Protein HIP1 Regulating AR and EGFR Pathways

    Using the Canadian Prostate Cancer Biomarker Network biobank, scientists analyzed UGT2B28 tumor expression in relation to clinical outcomes in men with localized prostate cancer.
    [Cancer Letters]

    Abstract

    SR9009 Inhibits Lethal Prostate Cancer Subtype 1 by Regulating the LXRα/FOXM1 Pathway Independently of REV-ERBs

    The authors found that SR9009 was specifically lethal to prostate cancer (PCa) cell lines but had no cytotoxic effect on prostate cells. SR9009 significantly inhibited colony formation, the cell cycle, and cell migration and promoted apoptosis in PCa cells.
    [Cell Death & Disease]

    Full Article

    Androgen Deprivation Restores ARHGEF2 to Promote Neuroendocrine Differentiation of Prostate Cancer

    Through analysis of RNA-seq data, researchers nominated ARHGEF2 as a pivotal androgen-repressed gene. They showed that ARHGEF2 was directly suppressed by androgen/androgen receptor.
    [Cell Death & Disease]

    Full Article

    Extensive Metabolic Consequences of Human Glycosyltransferase Gene Knockouts in Prostate Cancer

    The systemic metabolic consequences of UGT deficiencies were examined using untargeted and targeted mass spectrometry-based metabolomics profiling of carefully matched, treatment-naive prostate cancer cases.
    [British Journal of Cancer]

    Full Article

    Implications of Differential Transcription Start Site Selection on CML and Prostate Cancer Cell Protein Expression

    Scientists studied AGAP2 expression in prostate cancer and chronic myeloid leukemia, showing transcription was initiated from alternative transcription start sites (TSSs) within a single TSS cluster, producing cancer-type-specific AGAP2 mRNAs with small differences in their 5′ UTR length.
    [iScience]

    Full ArticleGraphical Abstract

    The ERα-NRF2 Signaling Axis Promotes Bicalutamide Resistance in Prostate Cancer

    Investigators performed bioinformatic analysis and immunohistochemical staining on normal and cancerous prostate tissue to evaluate ERα and NRF2 expression and their correlation.
    [Cell Communication and Signaling]

    Full Article

    Deubiquitinase USP35 Stabilizes BRPF1 to Activate Mevalonate (MVA) Metabolism during Prostate Tumorigenesis

    Researchers uncovered the biological roles of deubiquitylase USP35 in prostate adenocarcinoma and found effective epigenetic or metabolic targets.
    [Cell Death Discovery]

    Full Article

    The NOGO Receptor NgR2, a Novel αVβ3 Integrin Effector, Induces Neuroendocrine Differentiation in Prostate Cancer

    Scientists showed a novel pathway activated by αVβ3 that promoted neuroendocrine differentiation in prostate cancer. This novel pathway required the expression of a glycosylphosphatidylinositol-linked surface molecule, NgR2, also known as Nogo-66 receptor homolog 1.
    [Scientific Reports]

    Full Article
    New human primary cancer-sourced blood products, immune cell subsets, and more. Click to view products.
    REVIEWS

    Steroidogenesis in Castration-Resistant Prostate Cancer

    The authors overview the current evidence on the pathological androgen milieu by altered metabolism and transport in prostate cancer, leading to resistance to endocrine therapy.
    [Urologic Oncology-Seminars and Original investigations]

    Abstract

    NRF2 Modulation in TRAMP Mice: An In Vivo Model of Prostate Cancer

    Investigators analyze the current literature regarding the role of natural and synthetic compounds in modulating nuclear factor erythroid 2-related factor 2 (NRF2) pathway in transgenic adenocarcinoma of mouse prostate (TRAMP) mice, an in vivo model of prostate cancer.
    [Molecular Biology Reports]

    Abstract
    INDUSTRY AND POLICY NEWS

    Lynparza in Combination with Abiraterone Recommended for Approval in the EU by CHMP as 1st-Line Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer

    AstraZeneca and MSD’s Lynparza in combination with abiraterone and prednisone or prednisolone has been recommended for marketing authorization in the European Union for the treatment of adult patients with mCRPC for whom chemotherapy is not clinically indicated.
    [AstraZeneca]

    Press Release
    FEATURED EVENT

    Cell Culture Engineering XVIII

    April 23 – 28, 2023
    Cancun, Mexico

    > See All Events

    JOB OPPORTUNITIES

    Lead Research Associate – In Vivo Prostate Cancer Research

    Dana-Farber Cancer Institute – Boston, Massachusetts, United States

    Postdoctoral Research Scientist – Computational Analysis

    Columbia University in the City of New York – New York, New York, United States

    Senior Program Associate – Science in the City

    STEMCELL Technologies, Inc. – Boston, Massachusetts, United States

    Lecturer – Cell and Developmental Biology

    Imperial College London – London, England, United Kingdom

    Postdoctoral Research Associate – Oncology

    University of Illinois Chicago – Chicago, Illinois, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Prostate Cell News Twitter